Skip to main content
Erschienen in: International Urogynecology Journal 8/2022

08.11.2021 | Original Article

Host inflammatory response in women with vaginal epithelial abnormalities after pessary use

verfasst von: Aparna S. Ramaseshan, Colleen Mellen, David M. O’Sullivan, Christopher Nold, Paul K. Tulikangas

Erschienen in: International Urogynecology Journal | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Vaginal epithelial abnormalities (VEA) are a common complication associated with pessary use. The objective of this study was to determine if there is a host pro-inflammatory response associated with pessary use and VEA.

Methods

Patients wearing pessaries for at least two weeks for the management of pelvic organ prolapse and/or urinary incontinence were screened for eligibility. Vaginal swabs were collected from women with VEA (cases) and without VEA (controls). Cases were matched to controls in a 1:3 ratio. Cytokine analysis of the collected samples was performed using multiplex analysis to determine the concentrations of interleukin (IL)6, interferon alpha 2 (IFNα2), tumor necrosis factor alpha (TNFα) and IL1β. A cross-sectional analysis was performed, comparing vaginal cytokine concentrations in women with and without VEA.

Results

We enrolled 211 patients in this analysis: 50 cases and 161 controls. The median concentrations (pg/mL) of the four cytokines for cases and controls respectively were; IL6: 6.7 (IQR <2.9 [the lower limit of detection, LLD]-14.2) and < 2.9 (LLD) (IQR <2.9 [LLD]-5.5), IFNα2: 8.2 (IQR 6.1–13.9) and 7.9 (IQR 3.9–13.6), TNFα: 15.2 (IQR 6.1–30.4) and 4.68 (IQR <2.3 [LLD]-16.3), IL1β 195.7 (IQR 54.5–388.6) and 38.5 (IQR 6.7–154.9). The differences in median cytokine levels were statistically higher in cases for IL6, TNFα, and IL1β (all p < 0.001) compared to controls. Older age (OR: 1.062, 95% CI, 1.015–1.112), lower BMI (OR: 0.910, 95% CI, 0.839–0.986) and presence of VEA at last check (OR: 5.377, 95% CI, 2.049–14.108) were associated with higher odds of having VEA on multivariate analysis.

Conclusion

Pro-inflammatory cytokines, specifically IL6, TNFα, and IL1β, are elevated in pessary-wearing patients who have VEA. Additional prospective studies are needed to assess baseline vaginal inflammatory profiles before and after pessary placement to understand VEA formation in pessary patients.
Literatur
1.
Zurück zum Zitat Pott-Grinstein E, Newcomer JR. Gynecologists’ patterns of prescribing pessaries. J Reprod Med. 2001;46(3):205–8.PubMed Pott-Grinstein E, Newcomer JR. Gynecologists’ patterns of prescribing pessaries. J Reprod Med. 2001;46(3):205–8.PubMed
2.
Zurück zum Zitat Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol. 2007;196(4):1–8.CrossRef Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol. 2007;196(4):1–8.CrossRef
3.
Zurück zum Zitat Hanson LAM, Schulz JA, Flood CG, Cooley B, Tam F. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success. Int Urogynecol J. 2006;17(2):155–9.CrossRef Hanson LAM, Schulz JA, Flood CG, Cooley B, Tam F. Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success. Int Urogynecol J. 2006;17(2):155–9.CrossRef
4.
Zurück zum Zitat Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse. Int Urogynecol J. 2018;29(8):1123–8.CrossRef Yimphong T, Temtanakitpaisan T, Buppasiri P, Chongsomchai C, Kanchaiyaphum S. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse. Int Urogynecol J. 2018;29(8):1123–8.CrossRef
5.
Zurück zum Zitat Abdulaziz M, Stothers L, Lazare D. An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse. Can Urol Assoc J. 2015;9:E400–6.CrossRef Abdulaziz M, Stothers L, Lazare D. An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse. Can Urol Assoc J. 2015;9:E400–6.CrossRef
6.
Zurück zum Zitat Tenfelde S, Tell D, Thomas T, Kenton K. Quality of life in women who use pessaries for longer than 12 months. Female Pelvic Med Reconstr Surg. 2015;21(3):146–9.CrossRef Tenfelde S, Tell D, Thomas T, Kenton K. Quality of life in women who use pessaries for longer than 12 months. Female Pelvic Med Reconstr Surg. 2015;21(3):146–9.CrossRef
7.
Zurück zum Zitat Ramsay S, Tu LM, Tannenbaum C. Natural history of pessary use in women aged 65–74 versus 75 years and older with pelvic organ prolapse: a 12-year study. Int Urogynecol J Pelvic Floor Dysfunct. 2016;27(8):1201–7.CrossRef Ramsay S, Tu LM, Tannenbaum C. Natural history of pessary use in women aged 65–74 versus 75 years and older with pelvic organ prolapse: a 12-year study. Int Urogynecol J Pelvic Floor Dysfunct. 2016;27(8):1201–7.CrossRef
8.
Zurück zum Zitat Robert M, Schulz JA, Harvey MA, et al. Technical update on pessary use. J Obstet Gynaecol Canada. 2013;35(7):664–74.CrossRef Robert M, Schulz JA, Harvey MA, et al. Technical update on pessary use. J Obstet Gynaecol Canada. 2013;35(7):664–74.CrossRef
9.
Zurück zum Zitat Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100.CrossRef Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86–100.CrossRef
10.
Zurück zum Zitat Sheikh Z, Brooks PJ, Barzilay O, Fine N, Glogauer M. Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials. Mater (Basel, Switzerland). 2015;8(9):5671–5701. Sheikh Z, Brooks PJ, Barzilay O, Fine N, Glogauer M. Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials. Mater (Basel, Switzerland). 2015;8(9):5671–5701.
11.
Zurück zum Zitat Brown BN, Haschak MJ, Lopresti ST, Stahl EC. Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants. Semin Immunol. 2017;29:24–32.CrossRef Brown BN, Haschak MJ, Lopresti ST, Stahl EC. Effects of age-related shifts in cellular function and local microenvironment upon the innate immune response to implants. Semin Immunol. 2017;29:24–32.CrossRef
12.
Zurück zum Zitat Nolfi AL, Brown BN, Liang R, et al. Host response to synthetic mesh in women with mesh complications. Am J Obstet Gynecol. 2016;215(2):206.e1–8. Nolfi AL, Brown BN, Liang R, et al. Host response to synthetic mesh in women with mesh complications. Am J Obstet Gynecol. 2016;215(2):206.e1–8.
13.
Zurück zum Zitat Sharma P, Shahabi K, Spitzer R, Farrugia M, Kaul R, Yudin. Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study. PLoS ONE. 2018;13(12):e0207266. Sharma P, Shahabi K, Spitzer R, Farrugia M, Kaul R, Yudin. Cervico-vaginal inflammatory cytokine alterations after intrauterine contraceptive device insertion: A pilot study. PLoS ONE. 2018;13(12):e0207266.
14.
Zurück zum Zitat Propst K, Mellen C, Sullivan DMO, Tulikangas PK. Timing of office-based pessary care. Obstet Gynecol. 2020;135(1):100–5.CrossRef Propst K, Mellen C, Sullivan DMO, Tulikangas PK. Timing of office-based pessary care. Obstet Gynecol. 2020;135(1):100–5.CrossRef
15.
Zurück zum Zitat Leng S. McElhaneyJE, Walston JD, Xie D, Fedarko NS, Kuchel G. ELISA and multiplex technologies for cytokine measurement in inflammation and aging reseaearch. A Biol Sci Med Sci. 2008;63(8):879–84. Leng S. McElhaneyJE, Walston JD, Xie D, Fedarko NS, Kuchel G. ELISA and multiplex technologies for cytokine measurement in inflammation and aging reseaearch. A Biol Sci Med Sci. 2008;63(8):879–84.
16.
Zurück zum Zitat Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 9th ed. Philadelphia: Elseiver; 2018. Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology. 9th ed. Philadelphia: Elseiver; 2018.
17.
Zurück zum Zitat Jelovsek EJ, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369:1027–38.CrossRef Jelovsek EJ, Maher C, Barber MD. Pelvic organ prolapse. Lancet. 2007;369:1027–38.CrossRef
18.
Zurück zum Zitat Dessie SG, Armstrong K, Modest AM, Hacker M. Effect of vaginal estrogen on pessary use. Int Urogynecol J Pelvic Floor Dysfunct. 2016;71(9):1423–9.CrossRef Dessie SG, Armstrong K, Modest AM, Hacker M. Effect of vaginal estrogen on pessary use. Int Urogynecol J Pelvic Floor Dysfunct. 2016;71(9):1423–9.CrossRef
19.
Zurück zum Zitat Collins S, Beigi R, Mellen C, Sullivan DO, Tulikangas P. The effect of pessaries on the vaginal microenvironment. Am J Obstet Gynecol. 2017;212(1):60.e1–60.e6. Collins S, Beigi R, Mellen C, Sullivan DO, Tulikangas P. The effect of pessaries on the vaginal microenvironment. Am J Obstet Gynecol. 2017;212(1):60.e1–60.e6.
Metadaten
Titel
Host inflammatory response in women with vaginal epithelial abnormalities after pessary use
verfasst von
Aparna S. Ramaseshan
Colleen Mellen
David M. O’Sullivan
Christopher Nold
Paul K. Tulikangas
Publikationsdatum
08.11.2021
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 8/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-021-05001-8

Weitere Artikel der Ausgabe 8/2022

International Urogynecology Journal 8/2022 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.